Does infliximab increase complications after surgery for inflammatory bowel disease?
Open Access
- 21 January 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (10)
- https://doi.org/10.3410/m1-10
Abstract
Does infliximab increase complications after surgery for inflammatory bowel disease?This publication has 21 references indexed in Scilit:
- Does Infliximab Influence Surgical Morbidity of Ileal Pouch-Anal Anastomosis in Patients with Ulcerative Colitis?Diseases of the Colon & Rectum, 2007
- Medical Therapy for Crohn’s Disease: Top-Down or Step-Up?Digestive Diseases, 2007
- The Impact of Preoperative Immunomodulation on Pouch-Related Septic Complications After Ileal Pouch-Anal AnastomosisDiseases of the Colon & Rectum, 2007
- Coccidioidomycosis Pneumonia in a Nonendemic Area Associated with InfliximabSouthern Medical Journal, 2007
- Bacterial and opportunistic infections during anti-TNF therapyBest Practice & Research Clinical Rheumatology, 2006
- Should ileoanal pouch surgery be staged for patients with mucosal ulcerative colitis on immunosuppressives?International Journal of Colorectal Disease, 2006
- Pulmonary Infectious Complications Associated with Anti-TNF.ALPHA. Therapy (Infliximab) for Rheumatoid ArthritisInternal Medicine, 2006
- Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor AntagonistsClinical Infectious Diseases, 2004
- Azathioprine or 6-Mercaptopurine Before Colectomy for Ulcerative Colitis Is Not Associated With Increased Postoperative ComplicationsInflammatory Bowel Diseases, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentThe New England Journal of Medicine, 2001